Boditech Med Inc. (KOSDAQ:206640)

Market Cap	310.30B
Revenue (ttm)	144.17B
Net Income (ttm)	27.86B
Shares Out	21.79M
EPS (ttm)	1,272.37
PE Ratio	11.19
Forward PE	9.56
Dividend	150.00 (1.05%)
Ex-Dividend Date	Mar 31, 2025

Volume	35,180
Average Volume	49,467
Open	14,280
Previous Close	14,240
Day's Range	14,060 - 14,430
52-Week Range	13,350 - 21,050
Beta	0.17
RSI	51.73
Earnings Date	Aug 11, 2025

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 515
• Stock Exchange: KOSDAQ
• Ticker Symbol: 206640

Financial Performance

In 2024, Boditech Med's revenue was 138.16 billion, an increase of 2.94% compared to the previous year's 134.22 billion. Earnings were 27.26 billion, an increase of 5.06%.